Category: Fresenius Medical CareSyndicate content

Fresenius Medical Care sees strong profit growth in 2016

February 25, 2015 by MassDevice

Kidney dialysis specialist Fresenius Medical Care forecast strong profit growth in 2016

Fresenius Medical Care sees strong profit growth in 2016

(Reuters) - Kidney dialysis specialist Fresenius (NYSE:FMS) forecast strong profit growth in 2016 after more modest progress this year while it cuts costs to counter pressures on payments for treatment in the United States and moves into new healthcare services.

China halts anti-dumping probe into EU, Japan dialysis kit makers

December 17, 2014 by MassDevice

China closes out an anti-dumoing probe into foreign dialysis kit makers including Fresenius, Nikkiso and Nipro.

China halts anti-dumping probe into EU, Japan dialysis kit makers

CytoSorbents inks deal with Fresenius Medical Care

December 16, 2014 by Mark Hollmer

Fresenius Medical Care is slated to distribute CytoSorbents' cytokine blood purification filters in several countries as part of a new strategic partnership.

CytoSorbents inks deal with Fresenius Medical Care

UPDATED Dec. 16, 2015, with comment from CytoSorbents CEO Phillip Chan.

Fresenius Medical takes over U.S. healthcare group Cogent

November 13, 2014 by MassDevice

Fresenius Medical Care acquires Cogent Healthcare and its specialty physicians business for an unspecified amount as it looks to build a $5 billion coordinated care operation.

Fresenius Medical takes over U.S. healthcare group Cogent

Fresenius ends Russia joint venture, feels impact of Ukraine crisis

November 7, 2014 by Brad Perriello

Economic sanctions against Russia over the Ukraine crisis prompt Fresenius to scrap a Russian joint venture.

Fresenius ends Russia joint venture, feels impact of Ukraine crisis

Conor MedSystems can't slip $100 million breach of contract lawsuit | Medtech legal news for the week of May 26, 2014

May 26, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: J&J's Conor MedSystems can't slip $100M Biotronik lawsuit; Supreme Court declines review of Baxter/Fresenius patent row; Medtronic, Edwards ink $750M heart valve settlement; Pa. Supreme Court to review $28M Zimmer verdict; Laid off Italian workers sue Haemonetics.

J&J's Conor MedSystems can't slip $100M Biotronik lawsuit

May 20, 2014 by Brad Perriello

J&J's Conor Medsystems can't slip $100M Biotronik lawsuit

Supreme Court declines review of Baxter/Fresenius patent row

May 19, 2014 by Brad Perriello

Fresenius escapes for good a $24 million patent infringement loss to dialysis rival Baxter International after the U.S. Supreme court declines to review the case.

Supreme Court declines review of Baxter/Fresenius patent row